Skip to main content

metronidazole

Generic: METRONIDAZOLE·Brand: FLAGYL, FLAGYL ER, FLAGYL I.V., FLAGYL I.V. RTU IN PLASTIC CONTAINER, Flagyl, LIKMEZ, Likmez, METRO I.V., METRO I.V. IN PLASTIC CONTAINER, METROCREAM, METROGEL, METROGEL-VAGINAL, METROLOTION, METROMIDOL, METRONIDAZOLE, METRONIDAZOLE HYDROCHLORIDE, METRONIDAZOLE IN PLASTIC CONTAINER, MetroCream, MetroGel, MetroLotion, NORITATE, NUVESSA, Noritate, Nuvessa, Nydamax, PROTOSTAT, Pylera, Relfy, Rosadan, SATRIC, VANDAZOLE, Vandazole

metronidazole: 6 clinical trials tracked.

metronidazole evidence translation

What we can confirm

6 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about metronidazole, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 0 study sponsors

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (6)

Comparing Placebo Versus Antibiotics for Acute Uncomplicated Diverticulitis

NCT07492134Registry updated 2026-07-08·Phase 2
Recruiting

Primary endpoint: Recruitment Rate

InterventionalRandomizedquadruple100 targetStarted 2026-07Completion 2028-101 site · United StatesVanderbilt University Medical Center

A Phase II Trial to Prevent Linear Growth Stunting and Malnutrition in Impoverished Children From a Low-Income Country by Treating Small Intestine Bacterial Overgrowth

NCT07451171Registry updated 2026-08-18·Phase 2
Recruiting

Primary endpoint: Conversion to Glucose Hydrogen Breath Test (GHBT) Negativity at Day 15

InterventionalRandomizedsingle60 targetStarted 2026-04Completion 2026-121 site · BangladeshUniversity of Virginia

Phase II Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

NCT06616597Registry updated 2026-02-19·Phase 2
Recruiting

Primary endpoint: Number of participants with PSA30 response

Interventionalopen58 targetStarted 2025-02Completion 2032-031 site · United StatesSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice: A PBRN Clinical Trial

NCT06131021Registry updated 2026-04-14·Phase 3
Completed

Primary endpoint: Probing Depth (PD) in millimeters

InterventionalRandomizeddouble236 enrolledStarted 2024-04Completion 2026-041 site · United StatesRutgers, The State University of New Jersey

PROMIZE: A Phase I/II Trial to Assess the Safety, Tolerability and Preliminary Anti-tumour Activity of Oral Combination Antibiotic Therapy to Modulate the Microbiome in Combination With Enzalutamide With Metastatic Castration Resistant Prostate Cancer (mCRPC).

NCT06126731Registry updated 2025-11-24·Phase 1
Recruiting

Primary endpoint: Confirm the safety and tolerability of the combination of amoxicillin plus metronidazole (2 weeks) followed by ciprofloxacin plus vancomycin (2 weeks) along with enzalutamide in Phase I in mCRPC patients.

Interventionalopen39 targetStarted 2023-11Completion 2027-062 sites · Switzerland, United KingdomInstitute of Cancer Research, United Kingdom

Pilot Trial of Fecal Microbiota Transplantation and Re-Introduction of Anti-PD-1 Therapy in dMMR Colorectal Adenocarcinoma Anti-PD-1 Non-Responders

NCT04729322Registry updated 2026-06-12·Phase 2
Active, not recruiting

Primary endpoint: Objective response rate

Interventionalopen15 targetStarted 2021-02Completion 2027-121 site · United StatesM.D. Anderson Cancer Center